Cyient DLM B2S transition and aerospace order book underpin growth inflection

Investment View: Growth Inflection Through B2S

In its July 27, 2026 company update, Motilal Oswal Financial Services reiterates its Buy rating on Cyient DLM Ltd. The broker views the company as being at a growth inflection as it evolves from a traditional electronics manufacturing services provider into a design-led, Build-to-Spec, or B2S, platform partner.

This shift is expected to increase Cyient DLM's participation across product design, engineering, qualification, manufacturing and lifecycle support. In Motilal Oswal's view, B2S work raises switching costs and can extend relationships from annual purchase orders to programmes lasting 10 to 15 years or more. B2S contributed about 6% of FY26 revenue, and the broker expects this to reach a double-digit share by FY28E. Successful execution could lift the margin profile from the current 9% to 11% range towards 13% to 14%.

Aerospace Platform and Order-Book Opportunity

Aerospace, which represented 38% of FY26 revenue, remains the core of the investment case. Motilal Oswal highlights long qualification cycles, high switching costs and platform lives exceeding 15 years.

Cyient DLM has a production contract for Battery Diode Modules on the Boeing 787, covering production, design and certification support. It subsequently secured a Boeing Global Services contract for precision-machined parts and assemblies. The broker also cites B2S wins including Deutsche Aircraft's D328eco programme and Skydrive's eVTOL project.

The report notes that the combined Airbus-Boeing backlog was about 16,683 aircraft in April 2026, representing over 12 years of work for the aerospace supply chain.

Industrial, Automotive and Altek Expansion

The broker sees Industrial and Automotive as additional growth pillars, with exposure to semiconductor equipment, AI infrastructure, clean energy, B2B smart metering and electric-vehicle battery-management systems.

Altek, Cyient DLM's US acquisition, adds a North American manufacturing footprint, ITAR-compliant capabilities and access to Industrial, MedTech and Defence customers. Altek reported FY26 year-on-year Industrial revenue growth of 425% and MedTech revenue growth of 142%.

Motilal Oswal identifies evidence of cross-selling: an existing Cyient DLM customer placed orders through Altek, while an Altek customer awarded business to Cyient DLM.

FY26 Financial Performance and Order Book

FY26 reported performance reflected the completion of a large, low-margin BEL defence order that accounted for 32% of FY25 revenue. Consolidated operating revenue declined 17.0% year on year to Rs 12,615 million in FY26. EBITDA was Rs 1,302 million, with the margin improving to 10.3% from 9.6% in FY25. Reported PAT was Rs 733 million, while adjusted PAT was Rs 571 million, down 22.7% year on year.

The broker considers the revenue base normalised after the BEL order. Cyient DLM ended FY26 with an order book of Rs 24.2 billion, up 27% year on year. The book-to-bill ratio was about 1.9 times, compared with 1.25 times in FY25, while FY26 order inflows rose 41%.

Estimates and Valuation

Motilal Oswal forecasts revenue, EBITDA and adjusted PAT CAGRs of 27%, 40% and 67%, respectively, over FY26 to FY28.

The Rs 830 target price is based on 41 times FY28E EPS.

Key Execution Considerations

The report does not state any earnings-estimate revisions or discrete risk factors. Its thesis is centred on execution of B2S programmes, aerospace platform ramp-ups, Industrial and Automotive expansion, and Altek-related integration and cross-selling.